• A.J. te Velthuis studies why some viruses are deadly while others are harmless

    Thursday, Jan 6, 2022
    by Liz Fuller-Wright, Office of Communications; Catherine Zandonella, Office of the Dean for Research

    Viruses outnumber humans by about 400 trillion to one, and yet pandemics are rare. Why? Why do a few viruses inflict so much damage, when the vast majority are harmless or even helpful?

    Those questions drive A.J. te Velthuis, a virologist who joined Princeton’s molecular biology faculty in January 2021.

  • Using light, researchers coax bacteria and yeast, usually competitors, to cooperate in producing chemicals

    Thursday, Dec 2, 2021
    by Molly A. Seltzer

    Strains of microbes like yeast and E. coli can be engineered to produce useful chemicals and fuels, and can produce more fuel more efficiently by working together. The problem is that when grown together in co-cultures, the fastest-growing strain often outcompetes the others, causing the community to break down and stop chemical production. Now, Princeton researchers have discovered a new way to stabilize co-cultures of microbes using light.

  • Martin Jonikas selected as Howard Hughes Medical Investigator

    Thursday, Sep 30, 2021
    by Liz Fuller-Wright, Office of Communications

    Martin Jonikas, whose research investigates a tiny structure in green algae with the potential to revolutionize agriculture, health and energy, has been named a 2021 Howard Hughes Medical Institute (HHMI) Investigator.

  • Major alumni gift supports recently established Princeton Bioengineering Initiative

    Tuesday, Sep 14, 2021
    by the Office of Engineering Communications

    A major gift from alumni will provide the Princeton Bioengineering Initiative funding to pursue some of the biggest questions and opportunities emerging at the intersection of biology and engineering.

    The Gilbert S. Omenn, M.D, '61 and Martha A. Darling *70 Fund for Grand Challenges in Bioengineering will allow the recently created initiative to move rapidly on several fronts, including hiring post-doctoral investigators, seeding research, and starting a series of lectures on technical and societal frontiers of bioengineering.

  • NSF, U.S. DOE, Pew support new platform speeding up effort to turn crops into fuel

    Tuesday, Sep 7, 2021
    by Scott Lyon, the School of Engineering and Applied Science

    Princeton researchers have developed a new way to make fuel from cellulose—Earth's most abundant organic compound, found in all plant cells—speeding up a notoriously slow chemical process and in some cases doubling energy yields over comparable methods.

    Their platform uses a recently developed cellulose emulsion that makes it easier to metabolize the compound into other chemicals. Combining that emulsion with engineered microbes and a light-based genetic tool, the team showed that they could more efficiently make biofuels from cellulose.

  • Science Center QED entrepreneurship program supports Ploss Lab in fight against hepatitis B virus

    Wednesday, Jan 27, 2021
    by Catherine Zandonella, Office of the Dean for Research

    When Alexander Ploss’ team discovered a compound that blocks the cancer-causing hepatitis B virus in lab experiments, the Princeton associate professor of molecular biology immediately grasped the potential benefit for society. He also knew that laboratory findings typically require additional research before they are ready for testing in patients.

  • Kayothera, cancer therapeutics start-up spun out of Princeton, wins BIO 2021 Start-up Stadium Competition

    Friday, Aug 6, 2021
    by Jonathan Garaffa

    On July 27, the Biotechnology Innovation Organization (BIO) named cancer therapeutics and Princeton spin-out company Kayothera Inc. winner of its 2021 Start-up Stadium competition. The company was selected as the winner from 16 finalist companies who were judged on the strength of their commercially viable cutting-edge technologies and therapeutic solutions.


Subscribe to Bioengineering